Artificial intelligence is rapidly transforming the landscape of prostate cancer care, offering new opportunities to enhance diagnosis, refine surgical planning, and improve patient experience. In this session, Professor Nikhil Vasdev — a global leader in robotic surgery, urological oncology, and digital innovation — will guide secondary care clinicians through the emerging tools and technologies shaping the future of prostate cancer management.
Professor Vasdev will outline how AI‑driven platforms are being used to support earlier detection, risk stratification, and treatment decision‑making, including their role in optimising nerve‑sparing techniques and improving postoperative pain management. Drawing on his leadership in robotic surgery, translational research, and NHS cancer service transformation, he will discuss the practical realities of integrating AI into clinical pathways, including regulatory, operational, and workforce considerations.
The session will also highlight findings from real‑world studies, grants, and published research, demonstrating how AI can deliver measurable improvements in patient outcomes, safety, and experience. Designed for secondary care nurses, clinical nurse specialists, doctors, and allied health professionals, this session forms part of the Specialists Conference 2026 and offers a concise, evidence‑based overview of how AI can be harnessed today to shape tomorrow’s prostate cancer services.
